Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Orbimed Advisors10% Owner | Traws PharmaTRAW | Open-market buy | 04/16 | 04/28 | 597,729 sh | $1.67 | $998,207.43 | +98.7% |
OrbiMed Capital GP VIII10% Owner | Traws PharmaTRAW | Open-market buy | 04/16 | 04/28 | 597,729 sh | $1.67 | $998,207.43 | +98.7% |